AURA — AURA BIOSCIENCES INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About AURA BIOSCIENCES INC (AURA)
AURA BIOSCIENCES INC (AURA) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $7M. Across recent filings, tracked investors recorded 5 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in AURA
How many top investors track AURA
A small number of top investors own this.
AURA Ownership Composition
How AURA BIOSCIENCES INC is held across tracked investor types, based on reported 13F positions.
- Other98.1%
- Hedge Funds1.9%
Tracked investors reporting AURA
- Izzy EnglanderMar 31, 2026Millennium ManagementShares1.1MValue$7.3M% Portfolio0.00%
- Ken GriffinMar 31, 2026Citadel AdvisorsShares12.5KValue$83.6K% Portfolio0.00%
- Steve CohenMar 31, 2026Point72 Asset ManagementShares21.7KValue$145.2K% Portfolio0.00%
Recent activity
- $3.4MFeb 17, 2026
- $7.3MMay 15, 2026
- New$298.1KFeb 17, 2026
- New$83.6KMay 15, 2026
- New$145.2KMay 15, 2026
Frequently asked questions
- How many institutional investors hold AURA?
- 3 tracked institutional investors disclosed a position in AURA (AURA BIOSCIENCES INC) in their most recent 13F filing.
- Who is the largest institutional holder of AURA?
- Izzy Englander, Millennium Management, holds the largest disclosed position in AURA, valued at $7M.
- Did institutional ownership of AURA increase or decrease?
- Across recent 13F filings, tracked investors recorded 5 new positions, 0 increased, 0 reduced, and 0 fully exited AURA.
- Where does this AURA ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.